ApicHope Pharmaceutical Group Co., Ltd. (300723)
Market Closed
10 Aug, 06:57
XSHE XSHE Primary ¥
37. 30
-0.69
-1.8163%
¥
24.19B Market Cap
- P/E Ratio
0.84% Div Yield
15.16M Volume
- Eps
¥ 37.99
Previous Close Want to track 300723 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
300723 closed today lower at ¥37.3, a decrease of -1.8163% from yesterday's close, completing a monthly decrease of -0.5333% or -¥0.2. Over the past 12 months, 300723 stock gained 11.2437%.
300723 is not paying dividends to its shareholders.
The last earnings report, released on Apr 24, 2026, exceeded the consensus estimates by 0%. On average, the company has fell short of earnings expectations by -0.1438%, based on the last three reports.
ApicHope Pharmaceutical Group Co., Ltd. has completed 2 stock splits, with the recent split occurring on May 24, 2023.
The company's stock is traded on one exchange.
300723 Chart
People also search for
ApicHope Pharmaceutical Group Co., Ltd. (300723) FAQ
What is the stock price today?
The current price is ¥37.30.
On which exchange is it traded?
ApicHope Pharmaceutical Group Co., Ltd. is listed on XSHE.
What is its stock symbol?
The ticker symbol is 300723.
Does it pay dividends? What is the current yield?
Yes, It pays dividends and the current yield is 0.84%.
What is its market cap?
As of today, the market cap is 24.19B.
Has ApicHope Pharmaceutical Group Co., Ltd. ever had a stock split?
ApicHope Pharmaceutical Group Co., Ltd. had 2 splits and the recent split was on May 24, 2023.
ApicHope Pharmaceutical Group Co., Ltd. Profile
| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Hanxiong Li CEO | XSHE Exchange | CNE1000035J7 ISIN |
| China Country | 1,484 Employees | 3 Jun 2024 Last Dividend | 24 May 2023 Last Split | - IPO Date |
Overview
ApicHope Pharmaceutical Co., Ltd, initially founded as Yipinhong Pharmaceutical Co., Ltd in 2002, underwent a significant rebranding in December 2021 to its current name. The company operates out of Guangzhou, China, along with its subsidiaries, diving deep into the pharmaceutical industry's core activities. These include the research and development, production, and sale of a diverse range of pharmaceutical drugs. ApicHope has carved out a niche for itself, especially in pediatric medicines and chronic disease drugs, leveraging cutting-edge research and development strategies to meet the ever-evolving healthcare needs.
Products and Services
The company's extensive product lineup is categorized under pediatric medicines and chronic disease drugs, offering a wide range of treatments:
- Pediatric Medicines: ApicHope provides a variety of oral solutions, tablets, suspensions, and liquid products specifically designed for children. These include Fuganlin and Yiqi Jianpi Oral Liquid, Carboxymestrine Oral Solution, and Xiaoer Kechuanling Oral Liquid. These medicines are formulated to meet the delicate needs of children's physiology.
- Antibiotics and Antivirals: Among the antibiotics and antivirals, the company produces Clindamycin Hydrochloride Palmitate Dispersible Tablet, Acetylguitaricin Dry Suspension, and a range of other products for injection and oral consumption, treating a variety of infections and viral conditions.
- Chronic Disease Drugs: For chronic conditions, ApicHope offers drugs like Hepatocyte Growth Stimulating Hormone and Pentoxifylline for injections. Additionally, the lineup features Kangshen Granules, Uqingshu Granules, and Shenbai Lotion, catering to a spectrum of chronic health issues.
- Cardiovascular and Neurological Treatments: This category includes medications such as Amlodipine Benzenesulfonate Dispersible Tablets and Valsartan Amlodipine Tablets, as well as special formulations for neurological care like Tricorutin, Aceglutamide, Vinpocetine, and Doxofylline for injections.
- Respiratory Solutions: The company offers Ambroxol Hydrochloride Drop and Montelukast Sodium Granule among other products designed to alleviate respiratory conditions.
- Additional Offerings: Expanding its portfolio, ApicHope also distributes Venlafaxine Hydrochloride Sustained-Release Capsules and a variety of injections such as Levofloxacin Hydrochloride and Sodium Ozagrel, targeting various specialized medical needs.
Contact Information
Address: Yunrun Building
Phone: 86 20 2887 7666
Website: https://www.apichope.com
